Hematology/Oncology

Top Story

Online information on pancreatic cancer often above reading level of general population

May 4, 2016

Online health information regarding pancreatic cancer often overestimated the reading level of the general population and lacked accurate information about alternative therapeutic options, according to study results published in JAMA Surgery.

“As a pancreatic surgeon, I noticed a variable level of knowledge on the complex topic of treatment among my patients, as well as a variable level of research that patients and families have done during the treatment period,” Tara S. Kent, MD, MS, assistant professor of surgery at Harvard Medical School and program director of the general surgery residency at Beth Israel Deaconess Medical Center, told HemOnc Today. “The Internet is varied, so we wanted to see what information was most searchable, whether or not it was accurate, and whether it was written in a way that most people could understand.”

Stivarga increases OS in patients with unresectable HCC

May 4, 2016
Bayer announced results of its phase 3 RESORCE clinical trial, indicating Stivarga improved overall survival in patients with unresectable hepatocellular carcinoma.In…
In the Journals

ACP, AAIM call for changes to graduate medical education financing

May 4, 2016
The American College of Physicians and the Alliance for Academic Internal Medicine have issued a policy paper outlining recommendations for aligning graduate medical…

Oncology Nursing Society presents award to AACR CEO

May 4, 2016
Margaret Foti, PhD, MD (hc), CEO of the American Association for Cancer Research, received the Honorary Member Award at the opening ceremony of the Oncology Nursing…
Meeting News CoverageVideo

VIDEO: Some women with early-stage breast cancer can safely avoid adjuvant chemotherapy

May 4, 2016
NEW ORLEANS — Hatem Soliman, MD, assistant member of the women’s oncology and breast cancer department at Moffitt Cancer Center, discusses the implications…
More News Headlines »
CME

The Patient with Myelofibrosis

No commercial support for this activity.

Myelofibrosis is caused by abnormal stem cells in the bone marrow that cause the uncontrolled production of mature…
More »
Video
Meeting News Coverage

VIDEO: Trial demonstrates potential to move away from toxic chemotherapies for breast cancer

May 1, 2016
More »
Featured
CME Video

Optimizing the Management of Metastatic Melanoma: Clinical Insights for Selecting First-line Therapy

This activity is supported by an independent educational grant from Merck & Co., Inc.

The incidence of melanoma is continuing to increase worldwide. In recent years, the treatment landscape for this…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan morganatic-roan